Mechanical Dilatation of the Cervix at Elective Caesarean Section on Post-operative Morbidity
NCT ID: NCT05997498
Last Updated: 2023-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2023-08-30
2024-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Routine Cervical Dilatation at the Non-labour Caesarean Section and Its Influence on Postoperative Pain
NCT03513237
Incidence of Uterine Cesarean Scar Niche After Cesarean Delivery
NCT05900492
Effect of Abdominal Myofascial Release on Pain and Functional Outcomes of Neck in Females with Cesarean Section
NCT05979116
Mechanical Dilatation of the Cervix at Elective Caesarean Section to Reduce Post-Operative Blood Loss
NCT03444792
Digital Cervical and Cesarean Section
NCT03392077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Study participants and sample size This study will include pregnant women with a singleton fetus at term ≥37 weeks of gestation and will be scheduled for elective caesarean section. Eligible participants will be allocated either to the study group (women with intraoperative cervical dilatation) or the control group (women with no intraoperative cervical dilatation).
* Types of interventions Mechanical dilatation of the cervix using a finger, sponge forceps during non-labour caesarean section \*\*\*Randomization and Allocation A statistician prepared a computer-generated random tableand placed the group allocation in serially numbered closed opaque envelopes in a 1:1 ratio. Packing, sealing and numbering will be performed by two independent doctors other than the investigator.
Patients are allocated to either study group (cervical dilatation) or control group (no cervical dilatation). Allocation will be never changed after opening the envelopes. All patients are blinded to the allocation to avoid bias.
\*\*Neither the investigator nor the outcome assessor following up the patient postoperatively are aware whether the patient had undergone cervical dilation during the cesarean section or not (double-blinding). Randomization coding tables will be hidden from the investigator till the end of the study.
Group I (dilation group): in which mechanical cervical dilatation will be done.
Group II (Non-dilation group): in which no mechanical cervical dilatation will be done. \*\*\*\*\* \*\*\*Study procedure:
After taking informed written consent, the recruited patients will be subjected to the following:
Clinical examination:
* History: personal (age, duration of marriage), present (any current medical or surgical diseases and any current medication), Past (history of any medical disorder) and obstetric history (including Parity, Gestational age, obstetric complications). Indications for cesarean were determined as malposition of the fetal head, head-pelvis incompatibility, disrupted fetal heart rate.
* General examination: assessment of body mass index (BMI) ,vital data (pulse, blood pressure, temperature), cardiac and chest auscultation to exclude contraindications for anesthesia.
* Abdominal examination: assessment of fundal level, fetal lie and presentation liquor volume and previous scar if present.
* Vaginal examination: to exclude cervical changes.
* Ultrasound examination: to assess fetal viability, determine gestational age and exclude major anomalies.
Steps:
* Informed consent will be obtained from women who will be invited to participate in the research after an explanation of the benefits and risks of this trial.
* All caesarean sections will be performed by a senior registrar capable of doing uncomplicated elective cesarean sections.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Patients are allocated to either study group (cervical dilatation) or control group (no cervical dilatation). Allocation will be never changed after opening the envelopes. All patients are blinded to the allocation to avoid bias.
Neither the investigator nor the outcome assessor following up the patient postoperatively are aware whether the patient had undergone cervical dilation during the cesarean section or not (double-blinding). Randomization coding tables will be hidden from the investigator till the end of the study.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dilation group
mechanical cervical dilatation will be done.
mechanical cervical dilatation
mechanical cervical dilatation during elective cesarean section
control
in which no mechanical cervical dilatation will be done.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mechanical cervical dilatation
mechanical cervical dilatation during elective cesarean section
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Emergency Cesarean section
* Chorioamnionitis.
* Preterm caesarean section.
* Multiple gestations.
* Fever during admission.
* Rupture of membranes.
* Anemia
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beni-Suef University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara Abdallah Mohamed Salem
principle investigator/Lecturer of Gynecology and obstetrics Faculty of medicine Beni-Suef University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mechanical Dilatation CS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.